AURA
Price
$5.71
Change
-$0.23 (-3.87%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
298.34M
34 days until earnings call
HOWL
Price
$0.79
Change
-$0.12 (-13.19%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
35.53M
33 days until earnings call
Ad is loading...

AURA vs HOWL

Header iconAURA vs HOWL Comparison
Open Charts AURA vs HOWLBanner chart's image
Aura Biosciences
Price$5.71
Change-$0.23 (-3.87%)
Volume$12.1K
Capitalization298.34M
Werewolf Therapeutics
Price$0.79
Change-$0.12 (-13.19%)
Volume$2.96K
Capitalization35.53M
AURA vs HOWL Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. HOWL commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and HOWL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (AURA: $5.71 vs. HOWL: $0.79)
Brand notoriety: AURA and HOWL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 145% vs. HOWL: 200%
Market capitalization -- AURA: $298.34M vs. HOWL: $35.53M
AURA [@Biotechnology] is valued at $298.34M. HOWL’s [@Biotechnology] market capitalization is $35.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileHOWL’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • HOWL’s FA Score: 1 green, 4 red.
According to our system of comparison, both AURA and HOWL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 4 TA indicator(s) are bullish while HOWL’s TA Score has 4 bullish TA indicator(s).

  • AURA’s TA Score: 4 bullish, 4 bearish.
  • HOWL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both AURA and HOWL are a good buy in the short-term.

Price Growth

AURA (@Biotechnology) experienced а -3.87% price change this week, while HOWL (@Biotechnology) price change was -25.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

AURA is expected to report earnings on May 08, 2025.

HOWL is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURA($298M) has a higher market cap than HOWL($35.5M). AURA YTD gains are higher at: -27.737 vs. HOWL (-38.351). HOWL has higher annual earnings (EBITDA): -64.05M vs. AURA (-91.84M). AURA has more cash in the bank: 174M vs. HOWL (111M). AURA has less debt than HOWL: AURA (19.1M) vs HOWL (37.1M). HOWL has higher revenues than AURA: HOWL (1.89M) vs AURA (0).
AURAHOWLAURA / HOWL
Capitalization298M35.5M839%
EBITDA-91.84M-64.05M143%
Gain YTD-27.737-38.35172%
P/E RatioN/AN/A-
Revenue01.89M-
Total Cash174M111M157%
Total Debt19.1M37.1M51%
TECHNICAL ANALYSIS
Technical Analysis
AURAHOWL
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
77%
Bullish Trend about 1 month ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAFQX18.74N/A
N/A
Lord Abbett Affiliated R2
PMVQX23.85N/A
N/A
PGIM Quant Solutions Mid-Cap Val R6
GSWPX21.30N/A
N/A
Goldman Sachs Small/Mid Cap Growth P
JHFEX12.54N/A
N/A
JHancock Fundamental Equity Inc I
WHGOX11.93N/A
N/A
Westwood Income Opportunity Ultra

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with CCCC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
+4.76%
CCCC - AURA
47%
Loosely correlated
+5.92%
ABCL - AURA
47%
Loosely correlated
+6.22%
VRDN - AURA
46%
Loosely correlated
+4.06%
ABOS - AURA
46%
Loosely correlated
+0.47%
GBIO - AURA
46%
Loosely correlated
+0.57%
More

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with GBIO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
+4.81%
GBIO - HOWL
42%
Loosely correlated
+0.57%
AURA - HOWL
40%
Loosely correlated
+4.76%
ABOS - HOWL
38%
Loosely correlated
+0.47%
GNPX - HOWL
38%
Loosely correlated
+28.21%
ATOS - HOWL
36%
Loosely correlated
+5.62%
More